Changchun High-Tech Industry (Group) Co (SZSE:000661) Margin of Safety % (DCF Earnings Based): N/A (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:000661 Changchun High-Tech Industry (Group) Co Ltd SZSE:000661
84 GF Score
Price ¥74.76
GF Value ¥85.96
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Changchun High-Tech Industry (Group) Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Changchun High-Tech Industry (Group) Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SZSE:000661 vs ZTS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Changchun High-Tech Industry (Group) Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Changchun High-Tech Industry (Group) Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changchun High-Tech Industry (Group) Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Changchun High-Tech Industry (Group) Co's Margin of Safety % (DCF Earnings Based) falls into.


SZSE:000661
84GF Score
Changchun High-Tech Industry (Group) Co Ltd SZSE:000661
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Changchun High-Tech Industry (Group) Co (SZSE:000661) Overvalued in 2026?

Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co stock appears to be undervalued. The current stock price of ¥74.76 is trading 13% below its estimated GF Value™ of ¥85.96. GuruFocus considers Changchun High-Tech Industry (Group) Co to be Modestly Undervalued.

Key valuation signals for SZSE:000661:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥85.96 vs. price of ¥74.76 (13% below fair value)
  • GF Score™: 84/100 with 8 warning signs

No single metric tells the full story. See the SZSE:000661 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Changchun High-Tech Industry (Group) Co Business Description

Address Intersection of Zhenyu Street and Dongweishan Road, 27th Floor, Building B, Hi-Tech Hairong Plaza, Jilin Province, Changchun, CHN, 130012
Changchun High-Tech Industry (Group) Co Ltd is engaged in the production and sales of biopharmaceuticals, Chinese patent medicine production, and real estate development. The company operates its business through three segments. The Pharmaceuticals segment focuses on the research and development, manufacturing, and sales of genetically engineered biologics, human vaccines, traditional Chinese medicines, and chemical pharmaceuticals. The Real Estate segment is involved in property development and sales. The Services segment provides scientific research and technical support, along with leasing and various business-related services. It generates the majority of its revenue from the Pharmaceuticals segment.
84GF Score

Get the complete analysis for SZSE:000661

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥74.76
Price
¥85.96
GF Value